Expert: When It Comes To Personal Information, Digital Health Companies Need To Think Broadly
What the BetterHelp settlement can teach the medtech industry about data privacy
Executive Summary
Hogan Lovells partner Scott Loughlin spoke to Medtech Insight about data privacy for digital health companies in the wake of the FTC’s proposed $7.8m settlement with BetterHelp.
You may also be interested in...
News We’re Watching – FDA Mammography Update, SVB Collapse, Zoll's Data Breach, And More
News we are keeping an eye on this week includes the FDA’s first traditional market authorization for a COVID-19 test and its approval of a new neurological diagnostic. The agency also updated its device shortage list and revised mammography guidelines.
Increase Access To MedTech: AdvaMed’s Priorities For The 118th Congress
AdvaMed’s Medical Innovation Agenda for the 118th Congress emphasizes increased access to medical devices, from reimbursement for breakthrough devices to boosting America’s start-ups to closing the care disparities for underserved communities.
FDA FY 2024 Budget Includes 10% Funding Boost, But No Movement On Diagnostics
The FDA requested a 10% increase in budget authority for FY 2024, but diagnostic reform was left out of the proposal.